Cost-effectiveness of a mixed-gender aftercare program for substance abuse: Decomposing measured and unmeasured gender differences

Journal of Mental Health Policy and Economics

Volumn 10, Issue 4, 2007, Pages 207-219

  Yeom, Hyong Suk ^a   Shepard, Donald S ^b  

^a JAMES MADISON UNIVERSITY   (United States)

^b BRANDEIS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AFTERCARE; ALCOHOL ABUSE; ARTICLE; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DRUG ABUSE; DRUG DEPENDENCE; FEMALE; HEALTH CARE COST; HEALTH PROGRAM; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; RELAPSE; SEX DIFFERENCE; STANDARDIZATION; SUBSTANCE ABUSE;

ADULT; AFTERCARE; COST-BENEFIT ANALYSIS; FEMALE; HEALTH CARE COSTS; HUMANS; MALE; MASSACHUSETTS; MENTAL HEALTH SERVICES; SEX FACTORS; SUBSTANCE-RELATED DISORDERS;

EID: 38649125949     PISSN: 10914358     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Grella CE, Greenwell L. Substance abuse treatment for women: changes in settings where women received treatment and types of services provided, 1987-1998. J Behav Health Serv Res 2004; 31(4): 367-383.
2. Mark TL, Coffey RM, Vandivort-Warren R, Harwood HJ, King EC, the MHSA Spending Estimates Team. U.S. spending for mental health and substance abuse treatment, 1991-2001. Health Aff (Web Exclusive) 2005; W5: 133-142.
3. Substance Abuse & Mental Health Services Administration (SAMHSA). National Expenditures for Mental Health Services and Substance Abuse Treatment 1991-2001. Web link: http://www.samhsa.gov/ spendingestimates/chapter5.aspx.
4. Hodgins DC, El-Guebaly N, Addington J. Treatment of substance abusers: single or mixed gender programs? Addiction 1997; 92(7): 805-812.
5. Kaskutas LA, Zhang L, French MT, Witbrodt J. Women's programs versus mixed-gender day treatment: results from a randomized study. Addiction 2005; 100: 60-69.
6. Greenfield SF, Brooks AJ, Gordon SM, Green CA, Kropp F, McHugh RK, Lincoln M, Hien D, Miele GM. Substance abuse treatment entry, retention, and outcome in women: a review of the literature. Drug Alcohol Depend 2007; 86(1): 1-21.
7. Jerrell JM, Ridgely MS. Gender differences in the assessment of specialized treatments for substance abuse among people with severe mental illness. J Psychoactive Drugs 1995; 27(4): 347-355.
8. Weisner CM, McLellan AT. Report of the 'Blue Ribbon Task Force on Health Services Research at the National Institute on Drug Abuse. Rockville, MD: Department of Health and Human Services, National Institutes of Health, 2004. Web link: http://www.drugabuse.gov/about/ organization/nacda/HSRReport.pdf.
9. Shepard DS, McKay J, Love C, Strickler G, Bury-Maynard DP, Yeom HS, Constantine R, Calabro J. Cost-effectiveness of aftercare in drug abuse treatment. In: Abstract Book, York International Health Economics Association (iHEA). York, United Kingdom: University of York, 2001. Abstract 33G002, p. 91. Web link: http://www.healtheconomics.org/cgi-bin/ WebObjects/ihea.woa/6/wo/WcX65AjouBfj2pY1vfd2aK3Ot3w/1.13.9.0.
10. Shepard DS, Stason WB, Perry HM Jr, Carmen BA, Nagurney JT. Multivariate cost-effectiveness analysis: An application to optimizing ambulatory care for hypertension. Inquiry 1995; 32: 320-330.
11. Shepard DS, Larson MJ, Hoffmann NG. Cost-effectiveness of substance abuse services. Psychiatr Clin North Am 1999; 22(2): 385-400.
12. Oaxaca R. Male-female wage differentials in urban labor markets. Int Econ Rev 1973; 14(3): 693-709.
13. Gilligan C. In a Different Voice: Psychological Theory and Women's Development. Cambridge, MA: Harvard University Press; 1982.
14. Liang KY, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika 1986; 73(1): 13-22.
15. Shepard DS, Calabro JAB, Love CT, McKay JR, Tetreault J, Yeom HS. Counselor incentives to improve client retention in an outpatient substance abuse aftercare program. Adm Policy Ment Health 2006; 33: 629-835.
16. Daley M, Argeriou M, McCarty D. Substance abuse treatment for pregnant women: A window of opportunity? Addict Behav 1998; 23(2): 239-249.
17. Lex BW. Women and aubstance abuse: a general review in drug and alcohol abuse reviews (vol. 5). In: Watson RR, Ed. Addictive Behaviors in Women. Totowa, NJ: Human Press Inc.; 1994.
18. Marsh JC, Miller NA. Female clients in substance abuse treatment. Int J Addict 1985; 20(6-7): 995-1019.
19. Hser YI, Evans E, Huang YC. Treatment outcomes among women and methamphetamine abusers in California. J Subs Abuse Treat 2005; 28(1): 77-85.
20. Wong CJ, Badger GJ, Sigmon SC, Higgins ST. Examining possible gender differences among cocaine-dependent outpatients. Exp Clin Psychopharmacol 2002; 10: 316-323.
21. Green CA, Polen MR, Dickinson DM, Lynch FL, Bennett MD. Gender differences in predictors of initiation, retention, and completion in an HMO-based substance abuse treatment program. J Subs Abuse Treat 2002; 23: 285-295.
22. Alterman AI, Randall M, McLellan AT. Comparison of outcomes by gender and for fee-for-service versus managed care: a study of nine community programs. J Subst Abuse Treat 2000; 19(2): 127-134.
23. Downey L, Rosengren DB, Donovan DM. Gender, waitlists, and outcomes for public-sector drug treatment. J Subst Abuse Treat 2003; 25: 19-28.
24. Hser YI, Huang D, Teruya C, Douglas Anglin M. Gender comparisons of drug use treatment outcomes and predictors. Drug and Alcohol Depend 2003; 72(3): 255-264.
25. Stewart D, Gossop M, Marsden J, Kidd T, Treacy S. Similarities in outcomes for men and women after drug misuse treatment: results from the National Treatment Outcome Research Study (NTORS). Drug and Alcohol Rev 2003; 22(1): 35-41.
26. Weisner C, Mertens J, Parthasarathy S, Moore C, Hunkeler EM, Hu T, Selby JV. The outcome and cost of alcohol and drug treatment in an HMO: day hospital versus traditionally outpatient regimens. Health Serv Res 2000; 35(4): 791-803.
27. Uziel-Miller ND, Lyons JS, Kissiel C, Love S. Treatment needs and initial outcomes of a residential recovery program for Aftican-American women and their children. Am J Addict 1998; 7(1): 43-50.
28. Schumacher JE, Siegal SH, Socol C, Harkless S, Freeman K. Making evaluation work in a substance abuse treatment program for women with children: Olivia's House. J Psychoactive Drugs 1996; 28(1): 73-83.
29. Hagan TA, Finnegan LP, Nelson-Zlupko L. Impediments to comprehensive treatment models for substance-dependent women: treatment and research questions. J Psychoactive Drugs 1994; 26(2): 163-171.
30. Weiner HD, Wallen MC, Zankowski GL. Culture and social class as intervening variables in relapse prevention with chemically dependent women. J Psychoactive Drugs 1990; 22(2): 239-248.
31. Turner C, Lessler J, Devore J. Effects of mode of administration and wording on reporting of drug use. Survey measurement of drug use: Methodological studies, National Institute on Drug Abuse, 1992.
32. French MT, Salome HJ, Carney M. Using the DATCAP and ASI to estimate the costs and benefits of residential addiction treatment in the state of Washington. Soc Sci Med 2002; 55(12): 2267-2282.